Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3,5-dihydro-5-methyl-n-3-pyridinylbenzo(1,2-b:4,5-b')dipyrrole-1(2h)-carboxamide
2. 5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo(2,3-f)indole
3. Mpctpi
4. Sb 206553
5. Sb-206553
6. Sb206553
1. 158942-04-2
2. Sb 206553
3. Sb-206553
4. 1-methyl-n-pyridin-3-yl-6,7-dihydropyrrolo[2,3-f]indole-5-carboxamide
5. Tocris-1661
6. 5-methyl-n-(pyridin-3-yl)-2,3-dihydropyrrolo[2,3-f]indole-1(5h)-carboxamide
7. Sb206553
8. Chebi:8977
9. Chembl297784
10. Al4387525t
11. 3,5-dihydro-5-methyl-n-3-pyridinylbenzo(1,2-b:4,5-b')dipyrrole-1(2h)-carboxamide
12. Sb-206553 Hydrochloride Hydrate
13. Lopac-s-180
14. Sb-206,553
15. Lopac0_001163
16. Gtpl189
17. Schembl1459242
18. Zinc5994
19. Dtxsid9043984
20. Unii-al4387525t
21. Bdbm50060417
22. 5-methyl-n-(3-pyridinyl)-3,5-dihydropyrrolo[2,3-f]indole-1(2h)-carboxamide
23. Ccg-205237
24. Sdccgsbi-0051130.p002
25. Ncgc00015917-01
26. Ncgc00015917-02
27. Ncgc00015917-03
28. Ncgc00015917-04
29. Ncgc00015917-07
30. Ncgc00015917-10
31. Ncgc00015917-14
32. Ncgc00025248-01
33. Ncgc00025248-02
34. Sb-206533
35. A809980
36. L001241
37. Q7388905
38. Brd-k36395411-003-01-4
39. 1-methyl-n-(3-pyridyl)-6,7-dihydropyrrolo[2,3-f]indole-5-carboxamide
40. 1-methyl-n-pyridin-3-yl-6,7-dihydropyrrolo[2,3-f]indole-5-carboxamide;
41. 5-methyl-3,5-dihydro-2h-pyrrolo[2,3-f]indole-1-carboxylic Acid Pyridin-3-ylamide
42. Benzo[1,2-b:4,5-b']dipyrrole-1(2h)-carboxamide,3,5-dihydro-5-methyl-n-3-pyridinyl-
| Molecular Weight | 292.33 g/mol |
|---|---|
| Molecular Formula | C17H16N4O |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 292.13241115 g/mol |
| Monoisotopic Mass | 292.13241115 g/mol |
| Topological Polar Surface Area | 50.2 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 429 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
ABOUT THIS PAGE
97
PharmaCompass offers a list of Sb 206553 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sb 206553 manufacturer or Sb 206553 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sb 206553 manufacturer or Sb 206553 supplier.
PharmaCompass also assists you with knowing the Sb 206553 API Price utilized in the formulation of products. Sb 206553 API Price is not always fixed or binding as the Sb 206553 Price is obtained through a variety of data sources. The Sb 206553 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sb 206553 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sb 206553, including repackagers and relabelers. The FDA regulates Sb 206553 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sb 206553 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sb 206553 supplier is an individual or a company that provides Sb 206553 active pharmaceutical ingredient (API) or Sb 206553 finished formulations upon request. The Sb 206553 suppliers may include Sb 206553 API manufacturers, exporters, distributors and traders.
Sb 206553 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sb 206553 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sb 206553 GMP manufacturer or Sb 206553 GMP API supplier for your needs.
A Sb 206553 CoA (Certificate of Analysis) is a formal document that attests to Sb 206553's compliance with Sb 206553 specifications and serves as a tool for batch-level quality control.
Sb 206553 CoA mostly includes findings from lab analyses of a specific batch. For each Sb 206553 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sb 206553 may be tested according to a variety of international standards, such as European Pharmacopoeia (Sb 206553 EP), Sb 206553 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sb 206553 USP).
